Literature DB >> 26872908

Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls.

Gabriel C Camargo1,2, Tamara Rothstein3, Flavia P Junqueira3,2, Elsa Fernandes3, Andreas Greiser4, Ralph Strecker5, Viviani Pessoa6, Ronaldo S L Lima3,2, Ilan Gottlieb7,8.   

Abstract

Myocardial iron quantification remains limited to 1.5 T systems with T2* measurement. The present study aimed at comparing myocardial T2* values at 1.5 T to T1 and T2 mapping at 3.0 T in patients with iron overload and healthy controls. A total of 17 normal volunteers and seven patients with a history of myocardial iron overload were prospectively enrolled. Mid-interventricular septum T2*, native T1 and T2 times were quantified on the same day, using a multi-echo gradient-echo sequence at 1.5 T and T1 and T2 mapping sequences at 3.0 T, respectively. Subjects with myocardial iron overload (T2* < 20 ms) in comparison with those without had significantly lower mean myocardial T1 times (868.9 ± 120.2 vs. 1170.3 ± 25.0 ms P = 0.005 respectively) and T2 times (34.9 ± 4.7 vs. 45.1 ± 2.0 ms P = 0.007 respectively). 3 T T1 and T2 times strongly correlated with 1.5 T, T2* times (Pearson's r = 0.95 and 0.91 respectively). T1 and T2 measures presented less variability than T2* in inter- and intra-observer analysis. Native myocardial T1 and T2 times at 3 T correlate closely with T2* times at 1.5 T and may be useful for myocardial iron overload quantification.

Entities:  

Keywords:  3 Tesla; Iron overload; Magnetic resonance; Parametric mapping

Mesh:

Substances:

Year:  2016        PMID: 26872908     DOI: 10.1007/s12185-016-1950-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

1.  Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Authors:  B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

2.  Role of T2* magnetic resonance in monitoring iron chelation therapy.

Authors:  John-Paul Carpenter; Dudley J Pennell
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

Review 3.  T2* magnetic resonance and myocardial iron in thalassemia.

Authors:  Dudley J Pennell
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

4.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

5.  Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron.

Authors:  Ed X Wu; Daniel Kim; Christina L Tosti; Haiying Tang; Jens H Jensen; Jerry S Cheung; Li Feng; Wing-Yan Au; Shau-Yin Ha; Sujit S Sheth; Truman R Brown; Gary M Brittenham
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Gillian C Smith; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

7.  Myocardial T2 quantitation in patients with iron overload at 3 Tesla.

Authors:  Hua Guo; Wing-Yan Au; Jerry S Cheung; Daniel Kim; Jens H Jensen; Pek-Lan Khong; Queenie Chan; Kevin C Chan; Christina Tosti; Haiying Tang; Truman R Brown; Wynnie W M Lam; Shau-Yin Ha; Gary M Brittenham; Ed X Wu
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

8.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

9.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.

Authors:  Songtao Liu; Jing Han; Marcelo S Nacif; Jacquin Jones; Nadine Kawel; Peter Kellman; Christopher T Sibley; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-28       Impact factor: 5.364

10.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

View more
  8 in total

1.  Mathematical Development and Computational Analysis of Harmonic Phase-Magnetic Resonance Imaging (HARP-MRI) Based on Bloch Nuclear Magnetic Resonance (NMR) Diffusion Model for Myocardial Motion.

Authors:  Michael O Dada; Babatunde Jayeoba; Bamidele O Awojoyogbe; Uno E Uno; Oluseyi E Awe
Journal:  J Med Syst       Date:  2017-09-13       Impact factor: 4.460

2.  T1 and T2∗ relaxation time in the parcellated myocardium of healthy Taiwanese participants: A single center study.

Authors:  Chih-Chien Tsai; Shu-Hang Ng; Yao-Liang Chen; Yu-Hsiang Juan; Chao-Hung Wang; Gigin Lin; Chih-Wei Chien; Yu-Ching Lin; Yu-Chun Lin; Yu-Chieh Huang; Pei-Ching Huang; Jiun-Jie Wang
Journal:  Biomed J       Date:  2020-08-27       Impact factor: 7.892

Review 3.  T2 mapping in myocardial disease: a comprehensive review.

Authors:  Aaron T O'Brien; Katarzyna E Gil; Juliet Varghese; Orlando P Simonetti; Karolina M Zareba
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-06       Impact factor: 6.903

Review 4.  T1 mapping in cardiac MRI.

Authors:  Dina Radenkovic; Sebastian Weingärtner; Lewis Ricketts; James C Moon; Gabriella Captur
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 5.  Native T1 reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: A systematic review and meta-analysis.

Authors:  Maaike van den Boomen; Riemer H J A Slart; Enzo V Hulleman; Rudi A J O Dierckx; Birgitta K Velthuis; Pim van der Harst; David E Sosnovik; Ronald J H Borra; Niek H J Prakken
Journal:  J Magn Reson Imaging       Date:  2017-11-13       Impact factor: 4.813

6.  Using IVIM-MRI and R2⁎ Mapping to Differentiate Early Stage Liver Fibrosis in a Rat Model of Radiation-Induced Liver Fibrosis.

Authors:  Jianye Liang; Xiubao Song; Zeyu Xiao; Hanwei Chen; Changzheng Shi; Liangping Luo
Journal:  Biomed Res Int       Date:  2018-12-03       Impact factor: 3.411

7.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

Review 8.  Cardiac T2 * mapping: Techniques and clinical applications.

Authors:  Pandji Triadyaksa; Matthijs Oudkerk; Paul E Sijens
Journal:  J Magn Reson Imaging       Date:  2019-12-14       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.